Viewing Study NCT00912418


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2025-12-26 @ 3:50 AM
Study NCT ID: NCT00912418
Status: COMPLETED
Last Update Posted: 2020-03-02
First Post: 2009-06-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma
Sponsor: Craig L Slingluff, Jr
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module